| Name | Title | Contact Details |
|---|
When it comes to selecting a nursing home, you want as much information as possible. You’ll want to be sure that we offer skilled care. You’ll need to assure yourself that you’re dealing with a facility that’s thoroughly professional while also being genuinely caring and considerate at all times. And you’ll insist upon a commitment to service that goes well beyond the everyday.
NES Healthcare Group is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. NES Healthcare Group is based in Tiburon, CA. You can find more information on NES Healthcare Group at www.neshold.com
NextHealth Technologies (NHT), based in Denver CO, drives measurable medical cost reduction through a prescriptive analytics and consumer engagement platform. NextHealth’s proprietary SaaS platform integrates three foundational technologies - prescriptive analytics, behavioral economics, and multichannel consumer engagement. This end-to end, technology-enabled solution predicts risk reduction opportunities and then prescribes personalized member level actions or “nudges" to dramatically improve outcomes. NHT has been able to deliver a sustained and ground breaking 25% reduction in ER visits and over $17 per member per year in medical claims cost reduction for targeted commercial, ASO, and Medicaid populations. NHT offers over 30+ use cases including ER visit reduction, out-of-network reduction, and retention of high value individual members. NextHealth offers an at risk managed services contract based on 20% of causal claims savings. These results have led the company to be named by Gartner as one of the most innovative healthcare analytics vendors in the US. NHT’s multi-year software and managed services solution is currently contracted and supporting over 1.5 million members with some of the most reputable health plans in the country including: UnitedHealthcare, BlueCross BlueShield of Tennessee, and Colorado Access.
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Trius Therapeutics Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in San Diego, CA. To find more information about Trius Therapeutics Inc., please visit www.triusrx.com